Sign Out
Pregnancy: Etoricoxib is contraindicated in women who are pregnant or who may become pregnant. Etoricoxib should be avoided during the third trimester because use is associated with a risk of closure of fetal ductus arteriosus in utero and possibly persistent pulmonary hypertension of the newborn. In addition, the onset of labour may be delayed and its duration may be increased.
Lactation: Contraindicated in breastfeeding. Etoricoxib present in milk in animal studies.
